Guided Therapeutics (GTHP) EBITDA (2011 - 2026)
Guided Therapeutics (GTHP) reported EBITDA of -$476,000 for Q2 2026, compared with -$760,000 a year earlier.
Analysis
Guided Therapeutics (GTHP) EBITDA (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Guided Therapeutics' EBITDA came in at -$1.97 million; for FY2025, it was -$2.36 million.
- By year, EBITDA came in at -$2.1 million in FY2024, -$3.45 million in FY2023, -$3.33 million in FY2022 and -$2.35 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$1.5 million in Q2 2023 and a high of $1.69 million in Q3 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$300,000 (Q1 2026), -$707,000 (Q4 2025) and -$483,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 2.90 Bn |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 2.75 Bn |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 1.79 Bn |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 1.19 Bn |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 1.96 Bn |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 1.53 Bn |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 1.23 Bn |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 555.90 Mn |
| 10 | Guided Therapeutics | 14.48 Mn | 13.95 Mn | - | -436,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -436,000.00 |
| Mar 31, 2026 | -252,000.00 |
| Dec 31, 2025 | -652,000.00 |
| Sep 30, 2025 | -429,000.00 |
| Jun 30, 2025 | -692,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | -494,000.00 |
| Sep 30, 2024 | -537,000.00 |
| Jun 30, 2024 | -634,000.00 |
| Mar 31, 2024 | -325,000.00 |
| Dec 31, 2023 | -450,000.00 |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | -1.47 Mn |
| Mar 31, 2023 | -809,000.00 |
| Dec 31, 2022 | -913,000.00 |
| Sep 30, 2022 | -1.19 Mn |
| Jun 30, 2022 | -680,000.00 |
| Mar 31, 2022 | -402,000.00 |
| Dec 31, 2021 | -394,000.00 |
| Dec 31, 2020 | -167,000.00 |
API Access
Guided Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GTHP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();